These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27271200)

  • 1. International prescribing practices in obsessive-compulsive disorder (OCD).
    Brakoulias V; Starcevic V; Belloch A; Dell'Osso L; Ferrão YA; Fontenelle LF; Lochner C; Marazziti D; Martin A; Matsunaga H; Miguel EC; Reddy YC; do Rosário MC; Shavitt RG; Sundar AS; Stein DJ; Viswasam K
    Hum Psychopharmacol; 2016 Jul; 31(4):319-24. PubMed ID: 27271200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): An international collaboration.
    Brakoulias V; Starcevic V; Belloch A; Brown C; Ferrao YA; Fontenelle LF; Lochner C; Marazziti D; Matsunaga H; Miguel EC; Reddy YCJ; do Rosario MC; Shavitt RG; Shyam Sundar A; Stein DJ; Torres AR; Viswasam K
    Compr Psychiatry; 2017 Jul; 76():79-86. PubMed ID: 28433854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments used for obsessive-compulsive disorder-An international perspective.
    Brakoulias V; Starcevic V; Albert U; Arumugham SS; Bailey BE; Belloch A; Borda T; Dell'Osso L; Elias JA; Falkenstein MJ; Ferrao YA; Fontenelle LF; Jelinek L; Kalogeraki L; Kay B; Laurito LD; Lochner C; Maina G; Marazziti D; Martin A; Matsunaga H; Miguel EC; Morgado P; Mourikis I; Pasquini M; Perez Rivera R; Potluri S; Reddy JYC; Riemann BC; do Rosario MC; Shavitt RG; Stein DJ; Viswasam K; Wang Z; Fineberg NA
    Hum Psychopharmacol; 2019 Jan; 34(1):e2686. PubMed ID: 30628745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.
    Poppe C; Müller ST; Greil W; Walder A; Grohmann R; Stübner S
    J Affect Disord; 2016 Aug; 200():89-96. PubMed ID: 27130958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers.
    Van Ameringen M; Simpson W; Patterson B; Dell'Osso B; Fineberg N; Hollander E; Hranov L; Hranov G; Lochner C; Karamustafalioglu O; Marazziti D; Menchon JM; Nicolini H; Pallanti S; Stein DJ; Zohar J
    J Psychopharmacol; 2014 Jun; 28(6):596-602. PubMed ID: 24429223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for obsessive-compulsive disorder: Real-world evidence from a 10-year retrospective data analysis.
    Oh S; Cho S; Moon SY; Lee J; Kim M; Lee TY; Kwon JS
    Asian J Psychiatr; 2024 Jan; 91():103847. PubMed ID: 38029602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features of patients with obsessive-compulsive disorder showing different pharmacological responses].
    Sumitani S; Ueno S; Ishimoto Y; Taniguchi T; Tomotake M; Motoki I; Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(12):1282-92. PubMed ID: 17334085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
    Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National prescribing practices of adolescent psychiatrists for psychotropic medications in outpatient care in Finland.
    Haapasalo-Pesu KM; Saarijärvi S; Sorvaniemi M
    Nord J Psychiatry; 2003; 57(6):405-9. PubMed ID: 14630545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.
    Poyurovsky M; Weizman A; Weizman R
    CNS Drugs; 2004; 18(14):989-1010. PubMed ID: 15584769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity.
    Brakoulias V
    Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
    Nakamae T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for obsessive-compulsive disorder.
    Greist JH; Jefferson JW
    Br J Psychiatry Suppl; 1998; (35):64-70. PubMed ID: 9829028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
    Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M
    Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.
    Stewart SE; Jenike EA; Hezel DM; Stack DE; Dodman NH; Shuster L; Jenike MA
    J Clin Psychopharmacol; 2010 Feb; 30(1):34-9. PubMed ID: 20075645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
    Matsunaga H; Nagata T; Hayashida K; Ohya K; Kiriike N; Stein DJ
    J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder.
    Brakoulias V; Stockings E
    Expert Opin Pharmacother; 2019 Jan; 20(1):47-53. PubMed ID: 30360669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond.
    Fineberg NA; Reghunandanan S; Brown A; Pampaloni I
    Aust N Z J Psychiatry; 2013 Feb; 47(2):121-41. PubMed ID: 23125399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.